Comparison of preference-based utilities of the Short-Form 36 Health Survey and Health Utilities Index before and after treatment of patients with intermittent claudication

被引:23
作者
Bosch, JL
Halpern, E
Gazelle, GS
机构
[1] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Radiol,DATA Grp, Boston, MA 02114 USA
[2] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA
[3] Erasmus Univ, Med Ctr, Dept Epidemiol & Biostat, Rotterdam, Netherlands
关键词
health status; utilities; quality of life; Short-Form 36 Health Survey; Health Utilities Index; intermittent claudication; peripheral vascular disease;
D O I
10.1177/027298902320556091
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
The authors compared SF-36 utilities with Health Utilities Index (HUI) utilities (HUI2 and HUI3) assessed in patients with intermittent claudication. A total of 87 patients with intermittent claudication completed the SF-36 and HUI before and 1, 3, and 12 months after revascularization. Utilities were estimated using SF-36 and HUI published algorithms (i.e., both algorithms were based on standard-gamble utilities assessed in random samples of the general population). The utilities were compared using repeated-measures multivariate analysis of variance, paired t tests, and univariate linear regression analyses. Before treatment, the mean SF-36 and HUI3 utilities were the some (0.66 vs. 0.66, P = 0.92) and less than the mean HUI2 utility (0.70, P = 0.02). After treatment, all utilities showed improvement from before treatment (P < 0.05); the gain in utilities from treatment was lowest when using the SF-36 (e.g., 0.74, 0.80, 0.77 at 3 months for the SF-36, HUI2, and HUI3, respectively). The correlations of changes over time of the SF-36 with HUI2 utilities and of the SF-36 with HUI3 utilities were 0.39 and 0.49, respectively. The relationships between the SF-36 and HUI2 or HUI3 utilities were moderate to good (i.e., range-adjusted R-2 = 31% to 72%). The results suggest that SF-36 data can be transformed to preference-based utilities and be used for economic evaluation in health care. The gain in utilities from treatment, however, was less for SF-36 utilities than for HUI utilities.
引用
收藏
页码:403 / 409
页数:7
相关论文
共 17 条
[1]   Health-related quality of life after angioplasty and stent placement in patients with iliac artery occlusive disease - Results of a randomized controlled clinical trial [J].
Bosch, JL ;
van der Graaf, Y ;
Hunink, MGM .
CIRCULATION, 1999, 99 (24) :3155-3160
[2]   The relationship between descriptive and valuational quality-of-life measures in patients with intermittent claudication [J].
Bosch, JL ;
Hunink, MGM .
MEDICAL DECISION MAKING, 1996, 16 (03) :217-225
[3]   Comparison of the Health Utilities Index Mark 3 (HUI3) and the EuroQol EQ-5D in patients treated for intermittent claudication [J].
Bosch, JL ;
Hunink, MGM .
QUALITY OF LIFE RESEARCH, 2000, 9 (06) :591-601
[4]   The estimation of a preference-based measure of health from the SF-36 [J].
Brazier, J ;
Roberts, J ;
Deverill, M .
JOURNAL OF HEALTH ECONOMICS, 2002, 21 (02) :271-292
[5]   Deriving a preference-based single index from the UK SF-36 Health Survey [J].
Brazier, J ;
Usherwood, T ;
Harper, R ;
Thomas, K .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1998, 51 (11) :1115-1128
[6]   EuroQol: The current state of play [J].
Brooks, R .
HEALTH POLICY, 1996, 37 (01) :53-72
[7]   Multiattribute and single-attribute utility functions for the health utilities index mark 3 system [J].
Feeny, D ;
Furlong, W ;
Torrance, GW ;
Goldsmith, CH ;
Zhu, ZL ;
DePauw, S ;
Denton, M ;
Boyle, M .
MEDICAL CARE, 2002, 40 (02) :113-128
[8]   MULTIATTRIBUTE HEALTH-STATUS CLASSIFICATION SYSTEMS - HEALTH UTILITIES INDEX [J].
FEENY, D ;
FURLONG, W ;
BOYLE, M ;
TORRANCE, GW .
PHARMACOECONOMICS, 1995, 7 (06) :490-502
[9]   A comparison of preference assessment instruments used in a clinical trial: Responses to the visual analog scale from the EuroQol EQ-5D and the health utilities index [J].
Glick, HA ;
Polsky, D ;
Willke, RJ ;
Schulman, KA .
MEDICAL DECISION MAKING, 1999, 19 (03) :265-275
[10]  
Gold MR, 1996, COST EFFECTIVENESS H